Autoimmune bullous dermatoses: A review

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 203-210

  Patrício, Patrícia ^b   Ferreira, Carlos ^a   Gomes, Manuel Marques ^b   Filipe, Paulo ^b  

^a Internal Medicine 2 Department   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Autoimmune bullous dermatoses; Bullous dermatoses; Bullous pemphigoid and pemphigus vulgaris; Dermatitis herpetiformis and bullous systemic lupus erythematosus; Linear IgA dermatoses

Indexed keywords

AZATHIOPRINE; BULLOUS PEMPHIGOID ANTIGEN 1; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; EOTAXIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; SULFAPYRIDINE; TETRACYCLINE;

ACHLORHYDRIA; ANTIBODY BLOOD LEVEL; ATROPHY; AUTOIMMUNE DISEASE; BLISTER; BULLOUS PEMPHIGOID; BULLOUS SKIN DISEASE; BULLOUS SYSTEMIC LUPUS ERYTHEMATOSUS; BULLOUS SYSTEMIC LUPUS ERYTHEMATOUS; CELIAC DISEASE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DERMATITIS HERPETIFORMIS; DERMATOMYOSITIS; DESMOSOME; DIET; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EROSION; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC ANEMIA; HUMAN; IDIOPATHIC DISEASE; IMMUNOFLUORESCENCE TEST; INSULIN DEPENDENT DIABETES MELLITUS; LINEAR IMMUNOGLOBULIN A DISEASE; LOW DRUG DOSE; METHEMOGLOBINEMIA; MYASTHENIA GRAVIS; PEMPHIGUS VULGARIS; PERNICIOUS ANEMIA; REMISSION; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE; ULTRAVIOLET RADIATION; VESICULAR RASH;

EID: 69949160352     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04737.x     Document Type: Conference Paper

References (9)

1. Atzori, L., S. Deidda, & N. Aste. 2008. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari. G. Ital Dermatol. Venereol. 143: 1-8.
2. Takayuki, O., A.O. Miyo, T. Kazuyuki, et al. 2008. Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance. Int. Immunol. 20: 1351-1360.
3. Angela, N., H. Michael, & E. Rüdiger. 2009. B-Cell-Directed therapy for inflammatory skin diseases. J. Invest. Dermatol. 129: 289-301.
4. Dupuy, A., M. Viguier, C. Bédane, et al. Jan 2004. Treatment of refractory pemphigus vulgaris with rit-uximab (anti-CD20 monoclonal antibody). Arch. Der-matol. 140: 91-96.
5. A.R. Ahmed, et al. 2006. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. NEJM 355: 1772-1779.
6. Abenavoli, L., I. Proietti, L. Leggio, et al. 2006. Cutaneous manifestations in celiac disease. Wo r l d J. G a s-troenterol. 12: 843-852.
7. Antille, C., M. Frei, O. Sorg, et al. 2008. Amicrobial pustulosis of the folds associated with auto-immune disorders. A case report with an analysis of cytokine expression profile in skin lesions of cutaneous neu-trophilic lupus. Dermatology 216: 324-329.
8. Alahlafi, A.M., P. Wordsworth, & F. Wojnarowska. Mar 2004. The lupus band: do the autoantibodies target collagen VII? Br. J. Dermatol. 150: 504-510.
9. Alahlafi, A.M., P. Wordsworth, L. Lakasing, et al. 2004. The basement membrane zone in patients with systemic lupus erythematosus: immunofluorescence studies in the skin, kidney and amniochorion. Lupus 13: 594-600.